The clinical impact of gut microbiota in chronic kidney disease

被引:37
作者
Kim, So Mi [1 ]
Song, Il Han [2 ]
机构
[1] Dankook Univ Hosp, Dept Internal Med, Div Nephrol, Cheonan, South Korea
[2] Dankook Univ Hosp, Dept Internal Med, Div Hepatol, 201 Manghyang Ro, Cheonan 31116, South Korea
关键词
Renal insufficiency; chronic; Gastrointestinal microbiome; Dysbiosis; Uremic toxins; HUMAN COLONIC MICROBIOTA; TRIMETHYLAMINE-N-OXIDE; DIETARY FIBER INTAKE; P-CRESYL SULFATE; INDOXYL SULFATE; HEMODIALYSIS-PATIENTS; SYSTEMIC INFLAMMATION; SKELETAL RESISTANCE; MORTALITY RISK; RENAL-FAILURE;
D O I
10.3904/kjim.2020.411
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gut microorganisms play critical roles in both maintaining host homeostasis and the development of diverse diseases. Gut dysbiosis, an alteration of the composition and function of gut microorganisms, is commonly seen in patients with chronic kidney disease (CKD). CKD itself contributes to a disruption of the symbiotic relationship between the gut microbiota and the host, while the resulting gut dysbiosis may play a part in stage progression of CKD. This bidirectional relationship supports the concept that the gut microbiota is considered a novel focus for the pathogenesis and management of CKD. This article examines the interaction between the gut microbiota and the kidney, the mutual effects of dysbiosis and CKD, and possible treatment options to restore gut eubiosis, and reduce CKD progression and its related complications.
引用
收藏
页码:1305 / 1316
页数:12
相关论文
共 83 条
[41]  
Mafi A, 2018, FOOD FUNCT, V9, P4763, DOI [10.1039/C8FO00888D, 10.1039/c8fo00888d]
[42]   The impact of gut microbiota on kidney function and pathogenesis [J].
Mahmoodpoor, Fariba ;
Saadat, Yalda Rahbar ;
Barzegari, Abolfazl ;
Ardalan, Mohammadreza ;
Vahed, Sepideh Zununi .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 93 :412-419
[43]   Circulating Endotoxemia: A Novel Factor in Systemic Inflammation and Cardiovascular Disease in Chronic Kidney Disease [J].
McIntyre, Christopher W. ;
Harrison, Laura E. A. ;
Eldehni, M. Tarek ;
Jefferies, Helen J. ;
Szeto, Cheuk-Chun ;
John, Stephen G. ;
Sigrist, Mhairi K. ;
Burton, James O. ;
Hothi, Daljit ;
Korsheed, Shvan ;
Owen, Paul J. ;
Lai, Ka-Bik ;
Li, Philip K. T. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (01) :133-141
[44]   p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin [J].
Meijers, Bjoern K. I. ;
De Preter, Vicky ;
Verbeke, Kristin ;
Vanrenterghem, Yves ;
Evenepoel, Pieter .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (01) :219-224
[45]   Intestinal microbiome and fitness in kidney disease [J].
Meijers, Bjorn ;
Evenepoel, Pieter ;
Anders, Hans-Joachim .
NATURE REVIEWS NEPHROLOGY, 2019, 15 (09) :531-545
[46]  
Miyazaki T, 1997, KIDNEY INT, V52, pS15
[47]   Indoxyl sulphate inhibits osteoclast differentiation and function [J].
Mozar, Anais ;
Louvet, Loic ;
Godin, Corinne ;
Mentaverri, Romuald ;
Brazier, Michel ;
Kamel, Said ;
Massy, Ziad A. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (06) :2176-2181
[48]   Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier [J].
Neal, Matthew D. ;
Leaphart, Cynthia ;
Levy, Ryan ;
Prince, Jose ;
Billiar, Timothy R. ;
Watkins, Simon ;
Li, Jun ;
Cetin, Selma ;
Ford, Henri ;
Schreiber, Alan ;
Hackam, David J. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (05) :3070-3079
[49]   Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells [J].
Nii-Kono, T. ;
Iwasaki, Y. ;
Uchida, M. ;
Fujieda, A. ;
Hosokawa, A. ;
Motojima, M. ;
Yamato, H. ;
Kurokawa, K. ;
Fukagawa, M. .
KIDNEY INTERNATIONAL, 2007, 71 (08) :738-743
[50]   Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain [J].
Ohtsuki, S ;
Asaba, H ;
Takanaga, H ;
Deguchi, T ;
Hosoya, K ;
Otagiri, M ;
Terasaki, T .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (01) :57-66